Nurse Practitioner, Primary Care · Garden Grove, CA
NPI
1275035917
Since 2018
Specialty
Nurse Practitioner, Primary Care
Code 363LP2300X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
9896 Garden Grove Blvd
Garden Grove, CA, 92844
Phone (714) 636-3032
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$1.9M
12,425 prescriptions
Company payments, 2025
$2,253
From 14 companies
Medicare prescription drug claims, 2024
In 2024, the drug Jieun Shin prescribed most often to Medicare patients was Atorvastatin Calcium, with 983 prescriptions and refills. In total Jieun Shin wrote 12,425 Medicare prescriptions that cost $1.9M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-05-25.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Atorvastatin Calcium Generic | 983 | 2,013 | 265 | $5,120 |
| Amlodipine Besylate Generic | 597 | 1,145 | 147 | $1,610 |
| Losartan Potassium Generic | 533 | 1,107 | 136 | $2,480 |
| Metformin Hcl Generic | 489 | 898 | 112 | $1,663 |
| Vascepa Icosapent Ethyl | 427 | 530 | 95 | $178K |
| Omeprazole Generic | 384 | 545 | 147 | $1,939 |
| Azithromycin Generic | 347 | 347 | 264 | $918 |
| Losartan-Hydrochlorothiazide Losartan/Hydrochlorothiazide | 279 | 543 | 65 | $2,319 |
| Jardiance Empagliflozin | 243 | 296 | 44 | $170K |
| Levothyroxine Sodium Generic | 243 | 481 | 62 | $1,963 |
| Tamsulosin Hcl Generic | 210 | 402 | 58 | $1,606 |
| Triamcinolone Acetonide Generic | 208 | 228 | 102 | $2,428 |
| Glimepiride Generic | 200 | 372 | 44 | $1,406 |
| Tradjenta Linagliptin | 188 | 220 | 29 | $111K |
| Rosuvastatin Calcium Generic | 160 | 352 | 48 | $1,443 |
Brand drugs: 2,678 claims; generic drugs: 9,664 claims; opioid claims: 76.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jieun Shin $2,253 ($2,253 in general payments such as food, travel and fees) from 14 companies. The largest payer was Aimmune Therapeutics, Inc. with $658.
| Company | Payments | Amount |
|---|---|---|
| Aimmune Therapeutics, Inc. | 23 | $658 |
| AstraZeneca Pharmaceuticals LP AZN | 11 | $366 |
| Abbvie Inc. ABBV | 12 | $269 |
| Lilly USA, LLC LLY | 6 | $217 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $136 |
| Astellas Pharma US Inc 4503.T | 2 | $126 |
| Amgen Inc. AMGN | 4 | $94.75 |
| Novo Nordisk Inc NVO | 4 | $90.15 |
| Lundbeck LLC | 4 | $88.57 |
| Vivus LLC | 4 | $88.08 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.